BridgeMD
Compares treatment options for Gastrointestinal Stromal Tumor of Stomach
Official title MCB vs EUS-FNA for Preoperative Pathological Evaluation of Gastric SMT
ClinicalTrials.gov ID: NCT06748690
What this study is testing
- What it's testing
- Gastrointestinal stromal tumors (GISTs) are the most common submucosal tumors (SMTs) of the stomach. The 2022 European Society of Oncology ESMO Diagnosis and Treatment Guidelines recommend that GISTs undergo biopsy with a clear pathological diagnosis and should be removed unless there are significant complications.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Endoscopic evaluation considers gastric submucosal tumors (SMTs) with a diameter of ≥ 15mm
You likely can't join if
- Endoscopic non bulging lesions.
- The upper gastrointestinal lesions measured by Endoscopic Ultrasonography(EUS) are less than 15 mm.
- Lesions that do not require tissue collection (such as lipomas, varicose veins)
- Patients with cystic lesions
- The patient has uncorrectable coagulation dysfunction (International Normalized Ratio (INR)\>1.5 or platelet count\<50x109)
- Patients with portal hypertension
See the full eligibility criteria
- Endoscopic evaluation considers gastric submucosal tumors (SMTs) with a diameter of ≥ 15mm
- Endoscopic non bulging lesions.
- The upper gastrointestinal lesions measured by Endoscopic Ultrasonography(EUS) are less than 15 mm.
- Lesions that do not require tissue collection (such as lipomas, varicose veins)
- Patients with cystic lesions
- The patient has uncorrectable coagulation dysfunction (International Normalized Ratio (INR)\>1.5 or platelet count\<50x109)
- Patients with portal hypertension
- Patients with a history of upper gastrointestinal surgery
- Pregnant women
- Patients who refuse to participate in this clinical trial
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, Beijing Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, Beijing Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.